Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

December 27, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

News Daily News

AHA Stresses Benefit of Meds, Surgery for Obesity-Related Hypertension

Yael L. Maxwell

September 23, 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

Little Improvement Seen Over Two Decades in US Racial Health Disparities

News Daily News

Little Improvement Seen Over Two Decades in US Racial Health Disparities

March 15, 2021

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

News Daily News

Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic

Michael O'Riordan

January 12, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.